With her medical training still underway, MD-PhD student Holly Wobma launched a company with her colleagues to bring a stem cell therapy to market.
Researchers have developed three-dimensional "mini organs," made from stem cells, that could be used to model lung diseases.
Scientists have used a new gene-editing technology called CRISPR, to repair a genetic mutation responsible for vision loss in patient-derived stem cells.
Columbia researchers have developed a method to generate hypothalamic-like neurons from human pluripotent stem cells, which could aid the study of obesity.
A stem cell capable of regenerating both bone and cartilage has been identified in bone marrow of mice.